Bronchopulmonary Dysplasia
257
34
44
130
Key Insights
Highlights
Success Rate
87% trial completion (above average)
Published Results
37 trials with published results (14%)
Research Maturity
130 completed trials (51% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
7.8%
20 terminated out of 257 trials
86.7%
+0.1% vs benchmark
14%
37 trials in Phase 3/4
28%
37 of 130 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 130 completed trials
Clinical Trials (257)
Effects of a Physical Therapy Intervention on Motor Delay in Infants Admitted to a Neonatal Intensive Care Unit
Multidimensional Phenotype Classification in Grade 3 Bronchopulmonary Dysplasia
Lung Ultrasound Score for Early Prediction of Bronchopulmonary Dysplasia in Preterm Newborns
Effects of IVIG for BPD in Preterm Infant Born at 28 Weeks and Below
Transpyloric Versus Gastric Feeding in Bronchopulmonary Dysplasia
Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Reversibility of Bronchial Obstruction in Children Born Preterm
Pragmatic Research on Diuretic Management in Early BPD Pilot
Lipid Infusions to Optimize Nutrition Trial
Early Prediction of Bronchopulmonary Dysplasia in Preterm Infants Using Clinical Data
Frequent Standardized Oral Care Using Human Milk in the Neonatal Intensive Care Unit
Delivery Room CPAP in Extremely Low Birth Weight Infants
Randomized Controlled Crossover Trial of Postpyloric Feedings to Improve Pulmonary Outcomes in High-risk Preterm Infants
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants
OCTA Evaluation of Retinal Vascularization in Preterm Infants With or Without Bronchopulmonary Dysplasia
p16Ink4a in Bronchopulmonary Dysplasia in Children
High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants